Evidence map›Paper›PMID 28421119›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2017

Influences of Realgar-

Huan-Hua Xu, Fei-Ran Hao, Mei-Xi Wang, Si-Jia Ren, Ming Li, Hong-Ling Tan, Yu-Guang Wang, Xiang-Lin Tang, Cheng-Rong Xiao, Qian-De Liang and 2 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Pharmacology, Toxicology, and Rational Application of Cinnabar, Realgar, and Their Formulations.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Huan-Hua XuGuangdong Pharmaceutical University, Guangzhou 510006, China.
Fei-Ran HaoInstitute of Radiation Medicine, AMMS, Beijing 100850, China.
Mei-Xi WangGuangdong Pharmaceutical University, Guangzhou 510006, China.
Si-Jia RenInstitute of Radiation Medicine, AMMS, Beijing 100850, China.
Ming LiInstitute of Radiation Medicine, AMMS, Beijing 100850, China.
Hong-Ling TanInstitute of Radiation Medicine, AMMS, Beijing 100850, China.
Yu-Guang WangInstitute of Radiation Medicine, AMMS, Beijing 100850, China.
Xiang-Lin TangInstitute of Radiation Medicine, AMMS, Beijing 100850, China.
Cheng-Rong XiaoInstitute of Radiation Medicine, AMMS, Beijing 100850, China.
Qian-De LiangInstitute of Radiation Medicine, AMMS, Beijing 100850, China.
Yue GaoGuangdong Pharmaceutical University, Guangzhou 510006, China.ORCID 0000-0003-1131-5326
Zeng-Chun MaGuangdong Pharmaceutical University, Guangzhou 510006, China.ORCID 0000-0003-4543-1974
Institute of Occupational Medicine · GBGuangdong Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this work was to study the influences of Realgar-

Identifiers

PMID28421119
PMCPMC5379094
OpenAlexW2599853354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.